KERX Keryx Biopharmaceuticals, Inc.

-0.06  -1%
Previous Close 6.48
Open 6.51
Price To book 0.00
Market Cap 696.35M
Shares 108,466,000
Volume 633,141
Short Ratio 15.92
Av. Daily Volume 1,412,290

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved Sept 5, 2014.
(sNDA) PDUFA date November 6, 2017.
Iron deficiency anemia in non-dialysis dependent CKD patients

Latest News

  1. ETFs with exposure to Keryx Biopharmaceuticals, Inc. : May 22, 2017
  2. Top 4 Pharmaceutical Stocks for 2017
  3. Edited Transcript of KERX earnings conference call or presentation 4-May-17 12:00pm GMT
  4. Keryx Biopharmaceuticals, Inc. :KERX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017
  5. Keryx (KERX) Q1 Loss Wider than Expected, Revenues Beat
  6. Today's Research Reports on Biotech Stocks to Watch: BioCryst Pharmaceuticals and Keryx Biopharmaceuticals
  7. Keryx Biopharma reports 1Q loss
  8. Keryx (KERX) Posts Wider-than-Expected Q1 Loss, Sales Beat
  9. Investor Network: Keryx Biopharmaceuticals, Inc. to Host Earnings Call
  10. Keryx Biopharmaceuticals Announces First Quarter 2017 Financial Results
  11. Keryx Announces that Auryxia® (Ferric Citrate) is Now on Formulary at All Major Medicare Part D Plans
  12. What to Expect from Keryx (KERX) Stock This Earnings Season?
  13. Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2017 Financial Results on Thursday, May 4, 2017
  14. Lawsuit for Investors in NASDAQ: KERX Shares Against Keryx Biopharmaceuticals Announced by Shareholders Foundation
  15. ETFs with exposure to Keryx Biopharmaceuticals, Inc. : April 7, 2017
  16. Here's Why Keryx Biopharmaceuticals Jumped 27.3% in March
  17. Why Is Keryx (KERX) Up 27.4% Since the Last Earnings Report?
  18. Keryx's Auryxia Added to Largest Medicare Part D Plan
  19. Omeros and Keryx are Potential Beneficiaries of New Administration Deregulation